Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
As part of broad drug pricing deals with the Trump administration, more than two dozen pharma companies agreed to sell drugs to state Medicaid programs at prices available in peer countries under ...
Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.
Amid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that ...
Health secretary Kennedy announced a new effort to improve autism diagnoses, arguing that the current model is outdated ...
The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...
Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...
A gene therapy approved for Sanfilippo syndrome, good and bad news for Xenon Pharma, and more biotech news ...
Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news form Morning Rounds ...
We’re very actively hiring,” Karim Mikhail, director of FDA’s Center for Biologics Evaluation and Research, told drug ...
It wasn’t until he started medical school, Brian Zhang writes, that he realized ‘Asian glow’ from drinking was a sign of ...
A breast cancer drug from AstraZeneca will now be available in England after a pricing deal was reached, in part a result of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results